Europe In Vitro Diagnostics Market worth $49.49 billion by 2031
The report "Europe In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) - Forecast to 2031" is projected to grow from USD 33.83 billion in 2026 and to reach USD 49.49 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 7.9% during the forecast period.
Browse 95 market data Tables and 44 Figures spread through 200 Pages and in-depth TOC on "Europe In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-in-vitro-diagnostics-market-20552722.html
The in vitro diagnostics market in Europe is rapidly expanding due to the rising incidence of chronic and infectious diseases that require routine screening, diagnosis, and long-term monitoring. Another factor supporting faster, more accurate, and more convenient testing solutions is rapid technological advancements in various fields of molecular diagnostics, next-generation sequencing, laboratory automation, and point-of-care testing. On the other hand, expansion and modernization of healthcare infrastructure, including improved laboratory networks and wider diagnostic coverage in public health systems, contribute to sustaining high testing volumes and the continuous growth of the market.
The reagents & kits segment dominated the European in vitro diagnostics market in 2025 by product & service segment.
The in vitro diagnostics market in Europe is divided by product & service into reagents & kits, instruments, and data management software & services. Of these, the reagents & kits segment represents the largest market since these products are in constant demand across routine and specialized diagnostic testing, such as immunoassays, molecular diagnostics, clinical chemistry, and others. High test volumes, an increase in the number of screening programs, and extensive utilization in hospitals & clinics, clinical laboratories, and other healthcare settings maintain the steady demand for reagents and kits.
Immunoassay held the largest share of the Europe in vitro diagnostics market by technology segment in 2025.
On the basis of technology, the in vitro diagnostics market in Europe is divided into immunoassay, clinical chemistry, molecular diagnostics, glucose monitoring, hematology, microbiology, coagulation & hemostasis, blood gas analyzers, urinalysis, and chromatography & mass spectrometry. The immunoassays segment held the largest market share due to their widespread use in routine disease screening, infectious disease testing, hormone level analysis, and chronic disease monitoring. High testing volumes and established compatibility with automation, along with ongoing expansion of the assay menu, ensure its broad acceptance across all healthcare settings in Europe.
Some key players operating in the IVD market in Europe are F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), Siemens Healthineers AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), bioMérieux (France), Sysmex Corporation (Japan), Becton, Dickinson and Company (US), Werfen (Spain), and Illumina, Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Europe In Vitro Diagnostics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
